Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Pirfenex 400 mg Tablets
Pirfenex is a specialized formulation of Pirfenidone designed for the treatment of idiopathic pulmonary fibrosis (IPF). Each tablet contains 400 mg of Pirfenidone, a potent antifibrotic agent that helps in managing the symptoms and progression of IPF. By targeting the underlying inflammatory and fibrotic processes in the lungs, Pirfenex aims to improve patients' quality of life and lung function.
Uses of Pirfenex 400 mg Tablets
Idiopathic Pulmonary Fibrosis (IPF): Management of IPF to slow disease progression and improve lung function.
Reduction of Fibrosis: Helps in reducing the fibrotic changes in the lungs, which are characteristic of IPF.
Improving Quality of Life: Aids in enhancing the overall quality of life by stabilizing lung function and reducing symptoms associated with IPF.
Benefits of Pirfenex 400 mg Tablets
Slows Disease Progression: Effectively slows the progression of idiopathic pulmonary fibrosis, leading to a stabilization of lung function.
Reduces Fibrotic Changes: Decreases the amount of fibrosis in the lungs, which can improve breathing and overall lung health.
Improves Lung Function: Helps in maintaining better lung function and reducing the rate of decline in lung capacity.
Enhances Quality of Life: Contributes to a better quality of life by managing symptoms and reducing the impact of IPF on daily activities.
Long-Term Management: Provides long-term benefits in managing IPF, helping to prevent rapid deterioration of lung function.
Mechanism of Action of Pirfenex 400 mg Tablets
Pirfenidone: Pirfenidone works through multiple mechanisms to manage idiopathic pulmonary fibrosis. It acts as an antifibrotic agent by inhibiting fibroblast proliferation and collagen synthesis, which reduces the development of fibrotic tissue in the lungs. Additionally, it has anti-inflammatory properties that help to reduce inflammation in the lung tissue. By addressing both fibrosis and inflammation, Pirfenidone helps in stabilizing lung function and slowing the progression of IPF.